Henlius and Organon Announce US FDA Approval of POHERDY (pertuzumab-dpzb), the First PERJETA (pertuzumab) Biosimilar in the US
Shanghai Henlius Biotech, Inc. (2696.HK), and Organon (NYSE: OGN) today announced that the US Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for POHERDY...